Open AccessClinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain
Author(s) -
Jaime Rodríguez Quintosa,
Cintia Cristina Ago,
Renata Villoro,
Renata Villoro,
Inés Pérez-Román
Publication year - 2022
Publication title -
global and regional health technology assessment
Language(s) - English
Resource type - Journals
eISSN - 2283-5733
pISSN - 2284-2403
DOI - 10.33393/grhta.2022.2439
Subject(s) - impetigo , medicine , mupirocin , antibiotics , complication , dermatology , surgery , staphylococcus aureus , methicillin resistant staphylococcus aureus , biology , bacteria , microbiology and biotechnology , genetics
Impetigo is a common dermatological paediatric infection that can be treated with topical antibiotics: the common are mupirocin (MUP), fusidic acid (FA) and, most recently, ozenoxacin (OZ).